Published February 13, 2025 | Version v1
Journal article Open

New Approaches In The Diagnosis And Treatment Of Nonspecific Ulcerative Colitis

Description

Nonspecific ulcerative colitis (NUC) is a chronic inflammatory bowel disease characterized by inflammation and ulceration of the colonic mucosa. The disease presents with symptoms such as abdominal pain, diarrhea, rectal bleeding, and weight loss, significantly impacting the quality of life. Recent advancements in medical research have led to the development of innovative diagnostic and treatment approaches for NUC. Modern endoscopic techniques, biomarker analysis, and genetic studies have improved early diagnosis and disease monitoring. Additionally, targeted biological therapies, immunomodulators, and
personalized treatment strategies have enhanced disease management and patient outcomes. This paper discusses novel diagnostic methods and therapeutic approaches in the management of nonspecific ulcerative colitis, emphasizing the importance of an integrated and multidisciplinary treatment plan

Files

353-356.pdf

Files (231.9 kB)

Name Size Download all
md5:52b99848aea9a373acd9fab7b8696cb0
231.9 kB Preview Download

Additional details

Dates

Issued
2025-02-13
9

References

  • 1. Kozlova, I.V., Petrov, A.N. Modern approaches to the diagnosis and treatment of ulcerative colitis // Russian Journal of Gastroenterology. – 2022. – Vol. 32, No. 5. – P. 245–259. 2. Smith, J.D., Brown, K.A. Advances in biologic therapy for ulcerative colitis: A review of clinical trials // International Journal of Gastroenterology. – 2021. – Vol. 28, No. 3. – P. 135–149. 3. Ivanov, S.P., Mikhailov, R.O. The role of gut microbiota in inflammatory bowel diseases // Journal of Medical Research. – 2020. – Vol. 45, No. 7. – P. 89–102. 4. World Health Organization (WHO). Global epidemiology of inflammatory bowel diseases: Statistical review. – Geneva: WHO, 2019. – 187 p. 5. Taylor, L.W., Green, H.J. The effectiveness of fecal microbiota transplantation in ulcerative colitis: Systematic review and meta-analysis // Gut Health Research. – 2023. – Vol. 19, No. 2. – P. 77– 92. 6. Johnson, M.A., Stewart, P.C. Role of JAK inhibitors in the treatment of ulcerative colitis: Current perspectives // Clinical Gastroenterology. – 2022. – Vol. 41, No. 6. – P. 314–328. Russian Association of Gastroenterologists. Guidelines for the management of ulcerative colitis patients. – Moscow: Medizdat, 2021. – 96 p.